{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:59:34Z","timestamp":1791147574771,"version":"4.1.0"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":4017,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,9]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>A novel application of the implantable Port-a-Cath (PAC) system is described in the context of cellular transplantation. A silicone catheter was inserted in a collateral branch of the portal vein and connected to a port device positioned subcutaneously on the left thoracic cage. This permanent vascular access allowed iterative intraportal infusions of allogenic hepatocytes without the need of repeated transhepatic catheterization of the portal vein. Using this technique, repeated infusions of cryopreserved and \/ or fresh hepatocytes were successfully carried out in 3 children with inborn errors of liver metabolism, with the aim of progressively providing a sufficient mass of transplanted liver cells to stabilize the metabolic condition of the patients. We suggest that this technique might also be valuable in pancreatic islet cell transplantation. (Liver Transpl 2004;10:1213-1215.)<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/lt.20228","type":"journal-article","created":{"date-parts":[[2004,8,30]],"date-time":"2004-08-30T18:01:00Z","timestamp":1093888860000},"page":"1213-1215","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":75,"title":["Permanent access to the portal system for cellular transplantation using an implantable port device"],"prefix":"10.1097","volume":"10","author":[{"given":"Ahmed A.","family":"Darwish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Sokal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Stephenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha","family":"Najimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"de Ville de Goyet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Reding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-22-20250326","doi-asserted-by":"crossref","first-page":"14221426","DOI":"10.1056\/NEJM199805143382004","article-title":"Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation.","volume":"338","author":"Fox","year":"1998","journal-title":"N Engl J Med"},{"key":"R2-22-20250326","doi-asserted-by":"crossref","first-page":"735738","DOI":"10.1097\/01.TP.0000077420.81365.53","article-title":"Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up.","volume":"76","author":"Sokal","year":"2003","journal-title":"Transplantation"},{"key":"R3-22-20250326","doi-asserted-by":"crossref","first-page":"230238","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.","volume":"343","author":"Shapiro","year":"2000","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"R4-22-20250326","doi-asserted-by":"crossref","first-page":"S384S399","DOI":"10.1055\/s-2001-18597","article-title":"Islet transplantation: present clinical situation and future aspects.","volume":"109","author":"Bretzel","year":"2001","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R5-22-20250326","doi-asserted-by":"crossref","first-page":"613632","DOI":"10.1111\/j.1432-2277.2003.tb00361.x","article-title":"Technical aspects of islet preparation and transplantation.","volume":"16","author":"Lakey","year":"2003","journal-title":"Transpl Int"},{"key":"R6-22-20250326","doi-asserted-by":"crossref","first-page":"317318","DOI":"10.1016\/S0140-6736(02)07529-3","article-title":"Hepatocyte transplantation as a treatment for glycogen storage disease type 1a.","volume":"359","author":"Muraca","year":"2002","journal-title":"Lancet"},{"key":"R7-22-20250326","first-page":"263265","article-title":"Long-term venous access using subcutaneous implantable drug delivery system.","volume":"67","author":"Soo","year":"1985","journal-title":"Ann R Coll Surg Engl"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.20228","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-200409000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T19:15:52Z","timestamp":1743016552000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-200409000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":7,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.20228","relation":{},"ISSN":["1527-6465"],"issn-type":[{"value":"1527-6465","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}